CIK: 0001587143
Total reported value
$32.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Stock-Other | 35.88% | — | — | ||
| 2 | DCPHEUR | Deciphera Pharmaceuticals In | Stock-Other | 31.01% | — | — | |
| 3 | TRXCEUR | Transenterix INC | Stock-Other | 15.11% | — | — | |
| 4 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 9.62% | — | — | |
| 5 | OCUL | Ocular Therapeutix INC | Stock-Other | 3.86% | — | -22.42% | |
| 6 | ✓ | Arsanis INC | Stock-Other | 3.12% | — | — | |
| 7 | ✓ | Catabasis Pharmaceuticals In | Stock-Other | 1.26% | — | — | |
| 8 | ✓ | Enteromedics INC | Stock-Other | 0.16% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TRXCEUR | Transenterix INC | +5.5% | — | Unchanged |
| 2 | DCPHEUR | Deciphera Pharmaceuticals In | +5.2% | — | Unchanged |
| 3 | ✓ | Catabasis Pharmaceuticals In | -2.6% | — | Unchanged |
| 4 | OCUL | Ocular Therapeutix INC | -4% | -22.42% | Trim |
| 5 | 4XC1 | Kalvista Pharmaceuticals INC | -8.7% | — | Unchanged |
| 6 | ✓ | Arsanis INC | -29% | — | Unchanged |
| 7 | ✓ | — | NEW | New buy | |
| 8 | ✓ | Enteromedics INC | — | EXIT | Sold out |
| 9 | ✓ | Enteromedics INC | — | NEW | New buy |